| Genetic determinants of metamizole metabolism modify the risk of developing anaphylaxis E García-Martín, G Esguevillas, N Blanca-López, J García-Menaya, ... Pharmacogenetics and genomics 25 (9), 462-464, 2015 | 37 | 2015 |
| Gender and functional CYP2C and NAT2 polymorphisms determine the metabolic profile of metamizole C Martínez, I Andreu, G Amo, MA Miranda, G Esguevillas, MJ Torres, ... Biochemical pharmacology 92 (3), 457-466, 2014 | 33 | 2014 |
| NSAIDs hypersensitivity: questions not resolved N Blanca-Lopez, ML Somoza-Alvarez, T Bellon, G Amo, G Canto, ... Current Opinion in Allergy and Clinical Immunology 18 (4), 291-301, 2018 | 28 | 2018 |
| FCERI and histamine metabolism gene variability in selective responders to NSAIDS G Amo, JA Cornejo-García, JM García-Menaya, C Cordobes, MJ Torres, ... Frontiers in Pharmacology 7, 353, 2016 | 28 | 2016 |
| A Nonsynonymous FCER1B SNP is Associated with Risk of Developing Allergic Rhinitis and with IgE Levels G Amo, J García-Menaya, P Campo, C Cordobés, MCP Serón, P Ayuso, ... Scientific reports 6 (1), 19724, 2016 | 23 | 2016 |
| Gamma-aminobutyric acid (GABA) receptors genes polymorphisms and risk for restless legs syndrome FJ Jiménez-Jiménez, G Esguevillas, H Alonso-Navarro, M Zurdo, ... The Pharmacogenomics Journal 18 (4), 565-577, 2018 | 20 | 2018 |
| Gamma-aminobutyric acid (GABA) receptors GABRA4, GABRE, and GABRQ gene polymorphisms and risk for migraine E García-Martín, G Esguevillas, M Serrador, H Alonso-Navarro, ... Journal of Neural Transmission 125, 689-698, 2018 | 19 | 2018 |
| Clinical practice guidelines for translating pharmacogenomic knowledge to bedside. Focus on anticancer drugs JAG Agúndez, G Esguevillas, G Amo, E García-Martín Frontiers in Pharmacology 5, 82192, 2014 | 13 | 2014 |
| Identification of novel biomarkers for drug hypersensitivity after sequencing of the promoter area in 16 genes of the vitamin D pathway and the high-affinity IgE receptor G Amo, M Martí, JM García-Menaya, C Cordobés, JA Cornejo-García, ... Frontiers in Genetics 10, 582, 2019 | 12 | 2019 |
| Analysis of the Functional Polymorphism in the Cytochrome P450 CYP2C8 Gene rs11572080 with Regard to Colorectal Cancer Risk JM Ladero, JAG Agúndez, C Martínez, G Amo, P Ayuso, E García-Martín Frontiers in Genetics 3, 278, 2012 | 12 | 2012 |
| Increased serum diamine oxidase activity in nonallergic patients with migraine E García‐Martín, S Navarro‐Muñoz, G Amo, C Rodriguez, M Serrador, ... European journal of clinical investigation 52 (6), e13757, 2022 | 11 | 2022 |
| Serum vitamin D, vitamin D receptor and binding protein genes polymorphisms in restless legs syndrome FJ Jiménez-Jiménez, G Amo, H Alonso-Navarro, M Calleja, M Díez-Fairén, ... Journal of Neurology 268, 1461-1472, 2021 | 10 | 2021 |
| The role of phase I and II genetic polymorphisms, smoking, alcohol and cancer family history, in the risk of developing testicular cancer A Roco, A Lavanderos, JP Cayún, C Acevedo, C Celedón, JC Rubilar, ... Pharmacogenetics and Genomics 29 (7), 159-166, 2019 | 10 | 2019 |
| Asthma and allergic rhinitis associate with the rs2229542 variant that induces a p.Lys90Glu mutation and compromises AKR1B1 protein levels E García‐Martín, FJ Sánchez‐Gómez, G Amo, J García Menaya, ... Human Mutation 39 (8), 1081-1091, 2018 | 5 | 2018 |
| Pharmacogenomics testing for type B adverse drug reactions to anti-infective drugs: the example of hypersensitivity to abacavir. JA Agundez, G Esguevillas, G Amo, E Garcia-Martin Recent Patents on Anti-infective Drug Discovery 9 (2), 151-151, 2014 | 4 | 2014 |
| Correction to: Serum vitamin D, vitamin D receptor and binding protein genes polymorphisms in restless legs syndrome FJ Jiménez-Jiménez, A Gemma, H Alonso-Navarro, C Marisol, DF Mónica, ... Journal of Neurology 268 (4), 1473-1473, 2021 | | 2021 |
| NSAIDs hypersensitivity: questions not resolved (vol 18, pg 291, 2018) N Blanca-Lopez, ML Somoza-Alvarez, T Bellon, G Amo, G Canto, ... CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY 19 (5), 544-544, 2019 | | 2019 |
| Opinion Paper: Pharmacogenomics Testing for Type B Adverse Drug Reactions to Anti-Infective Drugs: The Example of Hypersensitivity to Abacavir J AG Agundez, G Esguevillas, G Amo, E García-Martín Recent Patents on Anti-Infective Drug Discovery 9 (2), 151-151, 2014 | | 2014 |
| CURRENT OPINION NSAIDs hypersensitivity: questions not resolved: Erratum M Blanca, G Amo | | |
| Asthma and allergic rhinitis associate with the rs2229542 (c. 268A> G) variant compromising AKR1B1 protein levels E García-Martín, FJ Sánchez-Gómez, G Amo, J García, D Pérez-Sala | | |
Elena Garcia-MartínDept. Farmacología, Universidad de ExtremaduraDirección de correo verificada de unex.es
